Goldman Sachs Group, Inc. (The) set a €97.00 ($115.48) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Tuesday. The firm currently has a buy rating on the stock.

Several other research analysts have also commented on the stock. J P Morgan Chase & Co set a €106.40 ($126.67) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Saturday, May 20th. Oddo Securities set a €95.00 ($113.10) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Monday, June 12th. Berenberg Bank set a €95.00 ($113.10) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, June 30th. Jefferies Group LLC set a €85.00 ($101.19) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Friday, June 16th. Finally, Deutsche Bank AG set a €85.00 ($101.19) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company. The stock presently has an average rating of Hold and an average target price of €88.39 ($105.22).

Fresenius Medical Care AG & Co. KGaA (ETR FME) opened at 81.453 on Tuesday. The company has a market cap of €24.99 billion and a price-to-earnings ratio of 21.004. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €70.82 and a 1-year high of €89.07. The company’s 50 day moving average is €79.19 and its 200 day moving average is €81.57.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/09/15/goldman-sachs-group-inc-the-analysts-give-fresenius-medical-care-ag-97-00-price-target.html.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.